International Health
Volume 1, Issue 2 , Pages 182-189 , December 2009

Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods

  • Elizabeth A. Cromwell

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
    • ,
  • Jeremiah Ngondi

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
    • Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK
    • ,
  • Gideon Gatpan

      Affiliations

    • The Carter Center, Munuki Industrial Area, Juba, Southern Sudan
    • ,
  • Steven Becknell

      Affiliations

    • The Carter Center, Munuki Industrial Area, Juba, Southern Sudan
    • ,
  • Lucia Kur

      Affiliations

    • Ministry of Health, Government of Southern Sudan, Juba, Southern Sudan
    • ,
  • Deborah McFarland

      Affiliations

    • Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
    • ,
  • Jonathan D. King

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
    • ,
  • Paul M. Emerson

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
    • Corresponding Author InformationCorresponding author.

Received 15 July 2009 ,Revised 24 August 2009 ,Accepted 3 September 2009.

References 

  1. World Health Organization. Prevention of Blindness and Deafness. Future Approaches to Trachoma Control. Geneva: World Health Organization Programme for the Prevention of Blindness and Deafness; 1997. Report No.: WHO/PBL/9656.
  2. World Health Organization. Trachoma control: a guide for program managers. Geneva; 2006.
  3. Zuber PL, Yameogo KR, Yameogo A, Otten MW. Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999. J Infect Dis. 2003;187(Supplement 1):S86–90
  4. Huhn GD, Brown J, Perea W, Berthe A, Otero H, LiBeau G, et al. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons–Liberia, 2004. Vaccine. 2006;24(6):730–737
  5. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342(8869):453–456
  6. Dawson C, Schachter J, Sallam S, Sheta A, Rubinstein R, Washton H. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis. 1997;24(3):363–368
  7. Ngondi J, Onsarigo A, Adamu L, Matende I, Baba S, Reacher M, et al. The epidemiology of trachoma in Eastern Equatoria and Upper Nile States, southern Sudan. Bull World Health Organ. 2005;83(12):904–912
  8. Ngondi J, Ole-Sempele F, Onsarigo A, Matende I, Baba S, Reacher M, et al. Blinding trachoma in postconflict Southern Sudan. PLoS Med. 2006;3(12):e478
  9. King JD, Ngondi J, Gatpan G, Lopidia B, Becknell S, Emerson PM. The burden of trachoma in Ayod county of southern Sudan. PLoS Negl Trop Dis. 2008;2(9):e299
  10. International Trachoma Initiative. Zithromax in the control of trachoma: a program manager's guide. New York; 2002.
  11. Turner AG, Magnani RJ, Shuaib M. A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) cluster survey design. Int J Epidemiol. 1996;25(1):198–203
  12. World Health Organization. Training for mid-level managers: The EPI coverage survey. Geneva: World Health Organization; 1991.
  13. Biritwum RB, Sylla M, Diarra T, Amankwa J, Brika GP, Assogba LA, et al. Evaluation of invermectin distribution in Benin, Cote d’Ivoire, Ghana and Togo: estimation of coverage of treatment and operational aspects of the distribution system. Ann Trop Med Parasitol. 1997;91(3):297–305
  14. Schwartz EC, Renk J, Hopkins AD, Huss R, Foster A. A method to determine the coverage of ivermectin distribution in onchocerciasis control programmes. Ann Trop Med Parasitol. 1998;92:793–796
  15. Brieger WR, Otusanya SA, Oke GA, Oshiname FO, Adeniyi JD. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State. Nigeria. Trop Med Int Health. 2002;7(1):11–18
  16. Mathieu E, Deming M, Lammie PJ, McLaughlin SI, Beach MJ, Deodat DJ, et al. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti. Trans R Soc Trop Med Hyg. 2003;97(5):501–505
  17. World Health Organization. Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Geneva; 2004.
  18. Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43(1):87–91
  19. Desmond N, Solomon AW, Massae PA, Lema N, Anemona A, Foster A, et al. Acceptability of azithromycin for the control of trachoma in Northern Tanzania. Trans R Soc Trop Med Hyg. 2005;99(9):656–663

PII: S1876-3413(09)00039-4

doi: 10.1016/j.inhe.2009.09.002

International Health
Volume 1, Issue 2 , Pages 182-189 , December 2009

Article Tools